Viral noncoding RNAs: More surprises

Genes and Development

Volumn 29, Issue 6, 2015, Pages 567-584

  Tycowski, Kazimierz T ^a   Guo, Yang Eric ^a   Lee, Nara ^a   Moss, Walter N ^a   Vallery, Tenaya K ^a   Xie, Mingyi ^a   Steitz, Joan A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene regulation; LncRNA; MiRNA; Ribonucleoprotein; SisRNA; Virus

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; LONG UNTRANSLATED RNA; MICRORNA; SINGLE STRANDED RNA; UNTRANSLATED RNA; VIRUS RNA;

ANIMAL VIRUS; BIOGENESIS; GENE SEQUENCE; HERPESVIRIDAE; HUMAN; INTRON; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SAIMIRIINE HERPESVIRUS 2; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; RNA VIRUS;

ANIMALIA; EUKARYOTA; RNA VIRUSES;

ANIMALS; GENE EXPRESSION REGULATION; MICRORNAS; RNA VIRUSES; RNA, UNTRANSLATED; RNA, VIRAL;

EID: 84925240058     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.259077.115     Document Type: Review

References (195)

1. Abend JR, Uldrick T, Ziegelbauer JM. 2010. Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression. J Virol 84: 12139-12151.
2. Abend JR, Ramalingam D, Kieffer-Kwon P, Uldrick TS, Yarchoan R, Ziegelbauer JM. 2012. Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, reduce inflammatory-cytokine expression. J Virol 86: 11663-11674.
3. Ahmed W, Philip PS, Tariq S, Khan G. 2014. Epstein-Barr virus- encoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells. PLoS One 9: e99163.
4. Albrecht JC, Fleckenstein B. 1992. Nucleotide sequence of HSUR 6 and HSUR 7, two small RNAs of Herpesvirus saimiri. Nucleic Acids Res 20: 1810.
5. Andersson MG, Haasnoot PC, Xu N, Berenjian S, Berkhout B, Akusjarvi G. 2005. Suppression of RNA interference by adenovirus virus-associated RNA. J Virol 79: 9556-9565.
6. Aparicio O, Razquin N, Zaratiegui M, Narvaiza I, Fortes P. 2006. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production. J Virol 80: 1376-1384.
7. Aparicio O, Carnero E, Abad X, Razquin N, Guruceaga E, Segura V, Fortes P. 2010. Adenovirus VA RNA-derived miRNAs target cellular genes involved in cell growth, gene expression and DNA repair. Nucleic Acids Res 38: 750-763.
8. Arvey A, Tempera I, Tsai K, Chen HS, Tikhmyanova N, Klichin- sky M, Leslie C, Lieberman PM. 2012. An atlas of the Epstein- Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe 12: 233-245.
9. Babiarz JE, Ruby JG, Wang Y, Bartel DP, Blelloch R. 2008. Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. Genes Dev 22: 2773-2785.
10. Baillat D, Hakimi MA, Naar AM, Shilatifard A, Cooch N, Shie- khattar R. 2005. Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II. Cell 123: 265-276.
11. Bekerman E, Jeon D, Ardolino M, Coscoy L. 2013. A role for host activation-induced cytidine deaminase in innate immune defense against KSHV. PLoS Pathog 9: e1003748.
12. Bellare P, Ganem D. 2009. Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 6: 570-575.
13. Bender BJ, Coen DM, Strang BL. 2014. Dynamic andnucleolin-de- pendent localization of human cytomegalovirus UL84 to the periphery of viral replication compartments and nucleoli. J Virol 88: 11738-11747.
14. Bhat RA, Thimmappaya B. 1983. Two small RNAs encoded by Epstein-Barr virus can functionally substitute for the virus-associated RNAs in the lytic growth of adenovirus 5. Proc Natl Acad Sci 80: 4789-4793.
15. Bidet K, Garcia-Blanco MA. 2014. Flaviviral RNAs: weapons and targets in the war between virus and host. Biochem J 462: 215-230.
16. Bidet K, Dadlani D, Garcia-Blanco MA. 2014. G3BP1, G3BP2 and CAPRIN1 are required for translation of interferon stimulated mRNAs and are targeted by a dengue virus non-coding RNA. PLoS Pathog 10: e1004242.
17. Blumberg BM, Leppert M, Kolakofsky D. 1981. Interaction of VSV leader RNA and nucleocapsid protein may control VSV genome replication. Cell 23: 837-845.
18. Bogerd HP, Karnowski HW, Cai X, Shin J, Pohlers M, Cullen BR. 2010. A mammalian herpesvirus uses noncanonical expression and processing mechanisms to generate viral Micro- RNAs. Mol Cell 37: 135-142.
19. Borah S, Darricarrere N, Darnell A, Myoung J, Steitz JA. 2011. A viral nuclear noncoding RNA binds re-localized poly(A) binding protein and is required for late KSHV gene expression. PLoS Pathog 7: e1002300.
20. Bowden RJ, Simas JP, Davis AJ, Efstathiou S. 1997. Murine y-her- pesvirus 68 encodes tRNA-like sequences which are expressed during latency. J Gen Virol 78: 1675-1687.
21. Brown JA, Valenstein ML, Yario TA, Tycowski KT, Steitz JA. 2012. Formation of triple-helical structures by the 3'-end sequences of MALAT1 and MENp noncoding RNAs. Proc Natl Acad Sci 109: 19202-19207.
22. Brown JA, Bulkley D, Wang J, Valenstein ML, Yario TA, Steitz TA, Steitz JA. 2014. Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix. Nat Struct Mol Biol 21: 633-640.
23. Buck AH, Perot J, Chisholm MA, Kumar DS, Tuddenham L, Cognat V, Marcinowski L, Dolken L, Pfeffer S. 2010. Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection. RNA 16: 307-315.
24. Burke JM, Bass CR, Kincaid RP, Sullivan CS. 2014. Identification of tri-phosphatase activity in the biogenesis of retroviral microRNAs and RNAP III-generated shRNAs. Nucleic Acids Res 42: 13949-13962.
25. Campbell M, Kim KY, Chang PC, Huerta S, Shevchenko B, Wang DH, Izumiya C, Kung HJ, Izumiya Y. 2014. A lytic viral long noncoding RNA modulates the function of a latent protein. J Virol 88: 1843-1848.
26. Cao S, Strong MJ, Wang X, Moss WN, Concha M, Lin Z, O'Grady T, Baddoo M, Fewell C, Renne R, et al. 2015. High-throughput RNA sequencing based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project. J Virol 89: 713-729.
27. Cazalla D, Yario T, Steitz JA. 2010. Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science 328:1563-1566.
28. Cazalla D, Xie M, Steitz JA. 2011. A primate herpesvirus uses the integrator complex to generate viral microRNAs. Mol Cell 43: 982-992.
29. Chapman EG, Costantino DA, Rabe JL, Moon SL, Wilusz J, Nix JC, Kieft JS. 2014a. The structural basis of pathogenic subge- nomic flavivirus RNA (sfRNA) production. Science 344: 307-310.
30. Chapman EG, Moon SL, Wilusz J, Kieft JS. 2014b. RNA structures that resist degradation by Xrn1 produce a pathogenic Dengue virus RNA. eLife 3: e01892.
31. Cheloufi S, Dos Santos CO, Chong MM, Hannon GJ. 2010. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 465: 584-589.
32. Chi SW, Zang JB, Mele A, Darnell RB. 2009. Argonaute HITS- CLIP decodes microRNA-mRNA interaction maps. Nature 460: 479-486.
33. Choy EY, Siu KL, Kok KH, Lung RW, Tsang CM, To KF, Kwong DL, Tsao SW, Jin DY. 2008. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205: 2551-2560.
34. Chu C, Qu K, Zhong FL, Artandi SE, Chang HY. 2011. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell 44: 667-678.
35. Cifuentes D, Xue H, Taylor DW, Patnode H, Mishima Y, Cheloufi S, Ma E, Mane S, Hannon GJ, Lawson ND, et al. 2010. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 328: 1694-1698.
36. Clarke PA, Sharp NA, Clemens MJ. 1990. Translational control by the Epstein-Barr virus small RNA EBER-1. Reversal of the double-stranded RNA-induced inhibition of protein synthesis in reticulocyte lysates. Eur J Biochem 193: 635-641.
37. Cliffe AR, Garber DA, Knipe DM. 2009. Transcription of the herpes simplex virus latency-associated transcript promotes theformation of facultative heterochromatin on lytic promoters. J Virol 83: 8182-8190.
38. Conrad NK, Steitz JA. 2005. A Kaposi's sarcoma virus RNA element that increases the nuclear abundance of intronless transcripts. EMBO J 24: 1831-1841.
39. Cook HL, Mischo HE, Steitz JA. 2004. The Herpesvirus saimiri small nuclear RNAs recruit AU-rich element-binding proteins but do not alter host AU-rich element-containing mRNA levels in virally transformed T cells. Mol Cell Biol 24: 4522-4533.
40. Cook HL, Lytle JR, Mischo HE, Li MJ, Rossi JJ, Silva DP, Desros- iers RC, Steitz JA. 2005. Small nuclear RNAs encoded by Herpesvirus saimiri upregulate the expression of genes linked to T cell activation in virally transformed T cells. Curr Biol 15: 974-979.
41. de Haro C, Mendez R, Santoyo J. 1996. The eIF-2a kinases and the control of protein synthesis. FASEB J 10: 1378-1387.
42. Diebel KW, Smith AL, van Dyk LF. 2010. Mature and functional viral miRNAs transcribed from novel RNA polymerase III promoters. RNA 16: 170-185.
43. Diebel KW, Oko LM, Medina EM, Niemeyer BF, Warren CJ, Claypool DJ, Tibbetts SA, Cool CD, Clambey ET, van DykLF. 2015. Gammaherpesvirus small noncoding RNAs are bifunctional elements that regulate infection and contribute to virulence in vivo. MBio 6: e01670-14.
44. Dominski Z, Yang XC, Marzluff WF. 2005. The polyadenylation factor CPSF-73 is involved in histone-pre-mRNA processing. Cell 123: 37-48.
45. Edwards RH, Marquitz AR, Raab-Traub N. 2008. Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J Virol 82: 9094-9106.
46. Eggington JM, Greene T, Bass BL. 2011. Predicting sites of ADAR editing in double-stranded RNA. Nat Commun 2: 319.
47. Ensser A, Fleckenstein B. 2005. T-cell transformation and oncogenesis by -y2-herpesviruses. Adv Cancer Res 93: 91-128.
48. Fan XC, Myer VE, Steitz JA. 1997. AU-rich elements target small nuclear RNAs as well as mRNAs for rapid degradation. Genes Dev 11: 2557-2568.
49. Farrell MJ, Dobson AT, Feldman LT. 1991. Herpes simplex virus latency-associated transcript is a stable intron. Proc Natl Acad Sci 88: 790-794.
50. Feederle R, Linnstaedt SD, Bannert H, Lips H, Bencun M, Cullen BR, Delecluse HJ. 2011. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog 7: e1001294.
51. Fok V, Friend K, Steitz JA. 2006. Epstein-Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling. J Cell Biol 173: 319-325.
52. Francoeur AM, Mathews MB. 1982. Interaction between VA RNA and the lupus antigen La: formation of a ribonucleopro- tein particle in vitro. Proc Natl Acad Sci 79: 6772-6776.
53. Ganem D. 2006. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 1: 273-296.
54. Gardner EJ, Nizami ZF, Talbot CC Jr, Gall JG. 2012. Stable intronic sequence RNA (sisRNA), a new class of noncoding RNA from the oocyte nucleus of Xenopus tropicalis. Genes Dev 26: 2550-2559.
55. Golembe TJ, Yong J, Battle DJ, Feng W, Wan L, Dreyfuss G. 2005. Lymphotropic Herpesvirus saimiri uses the SMN complex to assemble Sm cores on its small RNAs. Mol Cell Biol 25: 602-611.
56. Gottwein E, Cullen BR. 2010. A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J Virol 84: 5229-5237.
57. Gottwein E, Corcoran DL, Mukherjee N, Skalsky RL, Hafner M, Nusbaum JD, Shamulailatpam P, Love CL, Dave SS, Tuschl T, et al. 2011. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10: 515-526.
58. Greenaway PJ, Wilkinson GW. 1987. Nucleotide sequence of the most abundantly transcribed early gene of human cytomegalovirus strain AD169. Virus Res 7: 17-31.
59. Gregorovic G, Bosshard R, Karstegl CE, White RE, Pattle S, Chiang AK, Dittrich-Breiholz O, Kracht M, Russ R, Farrell PJ. 2011. Cellular gene expression that correlates with EBER expression in Epstein-Barr Virus-infected lymphoblastoid cell lines. J Virol 85: 3535-3545.
60. Grey F. 2014. The role of microRNAs in herpesvirus latency and persistence. J Gen Virol doi: 10.1099/vir.1090.070862-070860.
61. Grey F, Meyers H, White EA, Spector DH, Nelson J. 2007. A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication. PLoS Pathog 3: e163.
62. Guo YE, Steitz JA. 2014a. 3'-biotin-tagged microRNA-27 does not associate with Argonaute proteins in cells. RNA 20: 985-988.
63. Guo YE, Steitz JA. 2014b. Virus meets host microRNA: the destroyer, the booster, the hijacker. Mol Cell Biol 34:3780-3787.
64. Guo YE, Riley KJ, Iwasaki A, Steitz JA. 2014. Alternative capture of noncoding RNAs or protein-coding genes by herpesviruses to alter host T cell function. Mol Cell 54: 67-79.
65. Ha M, Kim VN. 2014. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15: 509-524.
66. Haecker I, Gay LA, Yang Y, Hu J, Morse AM, McIntyre LM, Renne R. 2012. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog 8: e1002884.
67. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Ber- ninger P, Rothballer A, Ascano M, Jungkamp AC, Munscha- uer M, et al. 2010. PAR-CliP - a method to identify transcriptome-wide the binding sites of RNA binding proteins. JVis Exp doi: 10.3791/2034.
68. Hesselberth JR. 2013. Lives that introns lead after splicing. Wiley Interdiscip Rev RNA 4: 677-691.
69. Hook LM, Grey F, Grabski R, Tirabassi R, Doyle T, Hancock M, Landais I, Jeng S, McWeeney S, Britt W, et al. 2014. Cytomegalovirus miRNAs target secretory pathway genes to facilitate formation of the virion assembly compartment and reduce cytokine secretion. Cell Host Microbe 15: 363-373.
70. Houmani JL, Davis CI, Ruf IK. 2009. Growth-promoting properties of Epstein-Barr virus EBER-1 RNA correlate with ribo- somal protein L22 binding. J Virol 83: 9844-9853.
71. Howe JG, Steitz JA. 1986. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci 83: 9006-9010.
72. Hutzinger R, Feederle R, Mrazek J, Schiefermeier N, Balwierz PJ, Zavolan M, Polacek N, Delecluse HJ, Huttenhofer A. 2009. Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome. PLoS Pathog 5: e1000547.
73. Imig J, Brunschweiger A, Brummer A, Guennewig B, Mittal N, Kishore S, Tsikrika P, Gerber AP, Zavolan M, Hall J. 2015. miR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction. Nat Chem Biol 11: 107-114.
74. Inman M, Perng GC, Henderson G, Ghiasi H, Nesburn AB, Wechsler SL, Jones C. 2001. Region of herpes simplex virus type 1 latency-associated transcript sufficient for wild-type spontaneous reactivation promotes cell survival in tissue culture. J Virol 75: 3636-3646.
75. Iwakiri D, Sheen TS, Chen JY, Huang DP, Takada K. 2005. Ep- stein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines. Oncogene 24: 1767-1773.
76. Iwakiri D, Zhou L, Samanta M, Matsumoto M, Ebihara T, Seya T, Imai S, Fujieda M, Kawa K, Takada K. 2009. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med 206:2091-2099.
77. Jeang KT, Hayward SD. 1983. Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphor- bol-13-acetate-induced mRNA transcript. J Virol 48: 135-148.
78. Jung YJ, Choi H, Kim H, Lee SK. 2014. MicroRNA miR-BART20- 5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1. J Virol 88: 9027-9037.
79. Kamel W, Segerman B, Oberg D, Punga T, Akusjarvi G. 2013. The adenovirus VA RNA-derived miRNAs are not essential for lytic virus growth in tissue culture cells. Nucleic Acids Res 41: 4802-4812.
80. Kang W, Mukerjee R, Gartner JJ, Hatzigeorgiou AG, Sandri- Goldin RM, Fraser NW. 2006. Characterization of a spliced exon product of herpes simplex type-1 latency-associated transcript in productively infected cells. Virology 356: 106-114.
81. Katsumura KR, Maruo S, Takada K. 2011. EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes. J Med Virol 84: 504-510.
82. Kelly GL, Long HM, Stylianou J, Thomas WA, Leese A, Bell AI, Bornkamm GW, Mautner J, Rickinson AB, Rowe M. 2009. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in Burkitt lym- phomagenesis: the Wp/BHRF1 link. PLoS Pathog 5: e1000341.
83. Kim S, Lee S, Shin J, Kim Y, Evnouchidou I, Kim D, Kim YK, Kim YE, Ahn JH, Riddell SR, et al. 2011. Human cytomegalovirus microRNA miR-US4-1 inhibits CD8+ T cell responses by targeting the aminopeptidase ERAP1. Nat Immunol 12: 984-991.
84. Kim Y, Lee S, Kim S, Kim D, Ahn JH, Ahn K. 2012. Human cytomegalovirus clinical strain-specific microRNA miR-UL148D targets the human chemokine RANTES during infection. PLoS Pathog 8: e1002577.
85. Kincaid RP, Burke JM, Sullivan CS. 2012. RNA virus microRNA that mimics a B-cell oncomiR. Proc Natl Acad Sci 109: 3077-3082.
86. Kincaid RP, Chen Y, Cox JE, Rethwilm A, Sullivan CS. 2014. Noncanonical microRNA (miRNA) biogenesis gives rise to retroviral mimics of lymphoproliferative and immunosuppressive host miRNAs. mBio 5: e00074.
87. Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, Naoe T, Yasukawa M, Hino K, Suzuki T, Todo S, et al. 2000. Ep- stein-Barr virus-encoded poly(A)- RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J19: 6742-6750.
88. Komano J, Maruo S, Kurozumi K, Oda T, Takada K. 1999. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J Virol 73: 9827-9831.
89. Krummenacher C, Zabolotny JM, Fraser NW. 1997. Selection of a nonconsensus branch point is influenced by an RNA stem- loop structure and is important to confer stability to the herpes simplex virus 2-kilobase latency-associated transcript. J Virol 71: 5849-5860
90. Kulesza CA, Shenk T. 2004. Human cytomegalovirus 5-kilobase immediate-early RNA is a stable intron. J Virol 78: 13182-13189.
91. Kulesza CA, Shenk T. 2006. Murine cytomegalovirus encodes a stable intron that facilitates persistent replication in the mouse. Proc Natl Acad Sci 103: 18302-18307.
92. Kurilla MG, Cabradilla CD, Holloway BP, Keene JD. 1984. Nucleotide sequence and host La protein interactions of rabies virus leader RNA. J Virol 50: 773-778.
93. Kwiatkowski DL, Thompson HW, Bloom DC. 2009. The polycomb group protein Bmi1 binds to the herpes simplex virus 1 latent genome and maintains repressive histone marks during latency. J Virol 83: 8173-8181.
94. Lee SI, Murthy SC, Trimble JJ, Desrosiers RC, Steitz JA. 1988. Four novel U RNAs are encoded by a herpesvirus. Cell 54: 599-607.
95. Lee N, Pimienta G, Steitz JA. 2012. AUF1/hnRNP D is a novel protein partner of the EBER1 noncoding RNA of Epstein- Barr virus. RNA 18: 2073-2082.
96. Lee N, Moss WN, Yario TA, Steitz JA. 2015. An EBV noncoding RNA base pairs with nascent RNA to enable PAX5 transcription factor binding to viral DNA. Cell 160: 607-618.
97. Lei X, Bai Z, Ye F, Xie J, Kim CG, Huang Y, Gao SJ. 2010. Regulation of NF-kB inhibitor LcBa and viral replication by a KSHV microRNA. Nat Cell Biol 12: 193-199.
98. Leppert M, Rittenhouse L, Perrault J, Summers DF, Kolakofsky D. 1979. Plus and minus strand leader RNAs in negative strand virus-infected cells. Cell 18: 735-747.
99. Lerner MR, Steitz JA. 1981. Snurps and scyrps. Cell 25: 298-300.
100. Lerner MR, Andrews NC, Miller G, Steitz JA. 1981. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci 78: 805-809.
101. Libri V, Helwak A, Miesen P, Santhakumar D, Borger JG, Kudla G, Grey F, Tollervey D, Buck AH. 2012. Murine cytomegalovirus encodes a miR-27 inhibitor disguised as a target. Proc Natl Acad Sci 109: 279-284.
102. Liu R, Yue L, Li X, Yu X, Zhao H, Jiang Z, Qin E, Qin C. 2010. Identification and characterization of small sub-genomic RNAs in dengue 1-4 virus-infected cell cultures and tissues. Biochem Biophys Res Commun 391: 1099-1103.
103. Lord PC, Rothschild CB, DeRose RT, Kilpatrick BA. 1989. Human cytomegalovirus RNAs immunoprecipitated by multiple systemic lupus erythematosus antisera. J Gen Virol 70: 2383-2396.
104. Lu S, Cullen BR. 2004. Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. J Virol 78: 12868-12876.
105. Lu F, Stedman W, Yousef M, Renne R, Lieberman PM. 2010. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J Virol 84: 2697-2706.
106. Macrae R. 2014. Uninvited guests. Cell 157: 761.
107. Marcinowski L, Tanguy M, Krmpotic A, Radle B, Lisnic VJ, Tud- denham L, Chane-Woon-Ming B, Ruzsics Z, Erhard F, Benkar- tek C, et al. 2012. Degradation of cellular mir-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo. PLoS Pathog 8: e1002510.
108. Mathews MB, Shenk T. 1991. Adenovirus virus-associated RNA and translation control. J Virol 65: 5657-5662.
109. Medina MF, Joshi S. 1999. RNA-polymerase III-driven expression cassettes in human gene therapy. Curr Opin Mol Ther 1: 580-594.
110. Medvedovic J, Ebert A, Tagoh H, Busslinger M. 2011. Pax5: amas- ter regulator of B cell development and leukemogenesis. Adv Immunol 111: 179-206.
111. Mitchell WJ, Deshmane SL, Dolan A, McGeoch DJ, Fraser NW. 1990. Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia. J Virol 64: 5342-5348.
112. Mitton-Fry RM, DeGregorio SJ, Wang J, Steitz TA, Steitz JA. Poly(A) tail recognition by a viral RNA element through assembly of a triple helix. Science 330: 1244-1247.
113. Moody R, Zhu Y, Huang Y, Cui X, Jones T, Bedolla R, Lei X, Bai Z, Gao SJ. 2013. KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways. PLoS Pathog 9: e1003857.
114. Moon SL, Anderson JR, Kumagai Y, Wilusz CJ, Akira S, Khromykh AA, Wilusz J. 2012. A noncoding RNA produced by arthropod-borne flaviviruses inhibits the cellular exoribonuclease XRN1 and alters host mRNA stability. RNA 18: 2029-2040.
115. Moss WN, Steitz JA. 2013. Genome-wide analyses of Epstein-Barr virus reveal conserved RNA structures and a novel stable intronic sequence RNA. BMC Genomics 14: 543-559.
116. Moss WN, Lee N, Pimienta G, Steitz JA. 2014. RNA families in Epstein-Barr virus. RNA Biol 11: 10-17.
117. Mukerjee R, Kang W, Suri V, Fraser NW. 2004. A non-consensus branch point plays an important role in determining the stability of the 2-kb LAT intron during acute and latent infections of herpes simplex virus type-1. Virology 324: 340-349.
118. Murphy E, Vanicek J, Robins H, Shenk T, Levine AJ. 2008. Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc Natl Acad Sci 105: 5453-5458.
119. Murthy SC, Trimble JJ, Desrosiers RC. 1989. Deletion mutants of Herpesvirus saimiri define an open reading frame necessary for transformation. J Virol 63: 3307-3314.
120. Myer VE, Lee SI, Steitz JA. 1992. Viral small nuclear ribonucleo- proteins bind a protein implicated in messenger RNA destabilization. Proc Natl Acad Sci 89: 1296-1300.
121. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O. 2009. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5: 376-385.
122. Nachmani D, Lankry D, Wolf DG, Mandelboim O. 2010. The human cytomegalovirus microRNA miR-UL112 acts synerg- istically with a cellular microRNA to escape immune elimination. Nat Immunol 11: 806-813.
123. Nikitin PA, Yan CM, Forte E, Bocedi A, Tourigny JP, White RE, Allday MJ, Patel A, Dave SS, Kim W, et al. 2010. An ATM/ Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells. Cell Host Microbe 8: 510-522.
124. Okamura K, Chung WJ, Ruby JG, Guo H, Bartel DP, Lai EC. 2008. The Drosophila hairpin RNA pathway generates endogenous short interfering RNAs. Nature 453: 803-806.
125. Ou Y, Davis KA, Traina-Dorge V, Gray WL. 2007. Simian varicella virus expresses a latency-associated transcript that is antisense to open reading frame 61 (ICP0) mRNA in neural ganglia of latently infected monkeys. J Virol 81: 8149-8156.
126. Peng W, Vitvitskaia O, Carpenter D, Wechsler SL, Jones C. 2008. Identification of two small RNAs within the first 1.5-kb of the herpes simplex virus type 1-encoded latency-associated transcript. J Neurovirol 14: 41-52.
127. Perez JT, Varble A, Sachidanandam R, Zlatev I, Manoharan M, Garcia-Sastre A, tenOever BR. 2010. Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc Natl Acad Sci 107: 11525-11530.
128. Perez JT, Zlatev I, Aggarwal S, Subramanian S, Sachidanandam R, Kim B, Manoharan M, tenOever BR. 2012. A small-RNA enhancer of viral polymerase activity. J Virol 86: 13475-13485.
129. Perng GC, Jones C, Ciacci-Zanella J, Stone M, Henderson G, Yukht A, Slanina SM, Hofman FM, Ghiasi H, Nesburn AB, et al. 2000. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287: 1500-1503.
130. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, et al. 2004. Identification of virus-encoded microRNAs. Science 304: 734-736.
131. Pijlman GP, Funk A, Kondratieva N, Leung J, Torres S, van der Aa L, Liu WJ, Palmenberg AC, Shi PY, Hall RA, et al. 2008. A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe 4: 579-591.
132. Pont AR, Sadri N, Hsiao SJ, Smith S, Schneider RJ. 2012. mRNA decay factor AUF1 maintains normal aging, telomere maintenance, and suppression of senescence by activation of telome- rase transcription. Mol Cell 47: 5-15.
133. Qiu J, Thorley-Lawson DA. 2014. EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells. Proc Natl Acad Sci 111: 11157-11162.
134. Reese TA, Xia J, Johnson LS, Zhou X, Zhang W, Virgin HW. 2010. Identification of novel microRNA-like molecules generated from herpesvirus and host tRNA transcripts. J Virol 84: 10344-10353.
135. Reeves MB, Davies AA, McSharry BP, Wilkinson GW, Sinclair JH. 2007. Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death. Science 316: 1345-1348.
136. Reich PR, Forget BG, Weissman SM. 1966. RNA of low molecular weight in KB cells infected with adenovirus type 2. J Mol Biol 17: 428-439.
137. Rennekamp AJ, Lieberman PM. 2011. Initiation of Epstein- Barr virus lytic replication requires transcription and the formation of a stable RNA-DNA hybrid molecule at OriLyt. J Virol 85: 2837-2850.
138. Riaz A, Dry I, Levy CS, Hopkins J, Grey F, Shaw DJ, Dalziel RG. 2014. Ovine herpesvirus-2-encoded microRNAs target virus genes involved in virus latency. J Gen Virol 95: 472-480.
139. Riley KJ, Rabinowitz GS, Steitz JA. 2010. Comprehensive analysis of Rhesus lymphocryptovirus microRNA expression. J Virol 84: 5148-5157.
140. Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, Steitz JA. 2012. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J 31: 2207-2221.
141. Roby JA, Pijlman GP, Wilusz J, Khromykh AA. 2014. Noncoding subgenomic flavivirus RNA: multiple functions in West Nile virus pathogenesis and modulation of host responses. Viruses 6: 404-427.
142. Rock DL, Beam SL, Mayfield JE. 1987. Mapping bovine herpesvirus type 1 latency-related RNA in trigeminal ganglia of latently infected rabbits. J Virol 61: 3827-3831.
143. Rodahl E, Haarr L. 1997. Analysis of the 2-kilobase latency-associated transcript expressed in PC12 cells productively infected with herpes simplex virus type 1: evidence for a stable, nonlinear structure. J Virol 71: 1703-1707.
144. Rosa MD, Gottlieb E, Lerner MR, Steitz JA. 1981. Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol Cell Biol 1: 785-796.
145. Rossetto CC, Pari G. 2012. KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome. PLoS Pathog 8: e1002680.
146. Rossetto CC, Tarrant-Elorza M, Verma S, Purushothaman P, Pari GS. 2013. Regulation of viral and cellular gene expression by Kaposi's sarcoma-associated herpesvirus polyadenylated nuclear RNA. J Virol 87: 5540-5553.
147. Rouha H, Thurner C, Mandl CW. 2010. Functional microRNA generated from a cytoplasmic RNA virus. Nucleic Acids Res 38: 8328-8337.
148. Ruby JG, Jan CH, Bartel DP. 2007. Intronic microRNA precursors that bypass Drosha processing. Nature 448: 83-86.
149. Sahin BB, Patel D, Conrad NK. 2010. Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways. PLoS Pathog 6: e1000799.
150. Schnettler E, Sterken MG, Leung JY, Metz SW, Geertsema C, Goldbach RW, Vlak JM, Kohl A, Khromykh AA, Pijlman GP. 2012. Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and mammalian cells. J Virol 86: 13486-13500.
151. Schuessler A, Funk A, Lazear HM, Cooper DA, Torres S, Daffis S, Jha BK, Kumagai Y, Takeuchi O, Hertzog P, et al. 2012. West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response. J Virol 86: 5708-5718.
152. Schwarz TM, Kulesza CA. 2014. Stability determinants of murine cytomegalovirus long noncoding RNA7.2. J Virol 88: 11630-11633.
153. Seto E, Moosmann A, Gromminger S, Walz N, Grundhoff A, Hammerschmidt W. 2010. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog 6: e1001063.
154. Shapiro JS, Varble A, Pham AM, Tenoever BR. 2010. Noncanon- ical cytoplasmic processing of viral microRNAs. RNA 16: 2068-2074.
155. Shen W, Sa e Silva M, Jaber T, Vitvitskaia O, Li S, Henderson G, Jones C. 2009. Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis. J Virol 83: 9131-9139.
156. Simon MD, Wang CI, Kharchenko PV, West JA, Chapman BA, Alekseyenko AA, Borowsky ML, Kuroda MI, Kingston RE. The genomic binding sites of a noncoding RNA. Proc Natl Acad Sci 108: 20497-20502.
157. Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D, Hafner M, Nusbaum JD, Feederle R, Delecluse HJ, Luftig MA, et al. The viral and cellular microRNA targetome in lympho- blastoid cell lines. PLoS Pathog 8: e1002484.
158. Soderlund H, Pettersson U, Vennstrom B, Philipson L, Mathews MB. 1976. Anew species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2. Cell 7: 585-593.
159. Spector DH. 1996. Activation and regulation of human cytomegalovirus early genes. Intervirology 39: 361-377.
160. Steitz J, Borah S, Cazalla D, Fok V, Lytle R, Mitton-Fry R, Riley K, Samji T. 2010. Noncoding RNPs of viral origin. Cold Spring Harb Perspect Biol 3: 165-179.
161. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, Horwitz E, Prokocimer Z, Prichard M, Hahn G, et al. 2007. Host immune system gene targeting by a viral miRNA. Science 317: 376-381.
162. Stern-Ginossar N, Weisburd B, Michalski A, Le VT, Hein MY, Huang SX, Ma M, Shen B, Qian SB, Hengel H, et al. 2012. Decoding human cytomegalovirus. Science 338: 1088-1093.
163. Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT. 1987. RNA complementary to a herpesvirus a gene mRNA is prominent in latently infected neurons. Science 235: 1056-1059.
164. Suffert G, Malterer G, Hausser J, Viiliainen J, Fender A, Contrant M, Ivacevic T, Benes V, Gros F, Voinnet O, et al. 2011. Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis. PLoS Pathog 7: e1002405.
165. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D. 2005. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435: 682-686.
166. Sun R, Lin SF, Gradoville L, Miller G. 1996. Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci 93: 11883-11888.
167. Swaminathan S, Tomkinson B, Kieff E. 1991. Recombinant Ep- stein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc Natl Acad Sci 88: 1546-1550.
168. Tan SM, Kirchner R, Jin J, Hofmann O, McReynolds L, Hide W, Lieberman J. 2014. Sequencing of captive target transcripts identifies the network of regulated genes and functions of primate-specific miR-522. Cell Rep 8: 1225-1239.
169. Tierney RJ, Kao KY, Nagra JK, Rickinson AB. 2011. Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains. J Virol 85: 12362-12375.
170. Toczyski DP, Steitz JA. 1991. EAP, a highly conserved cellular protein associated with Epstein-Barr virus small RNAs (EBERs). EMBO J10: 459-466.
171. Toczyski DP, Matera AG, Ward DC, Steitz JA. 1994. The Epstein- Barr virus (EBV) small RNA EBER1 binds and relocalizes ribo- somal protein L22 in EBV-infected human B lymphocytes. Proc Natl Acad Sci 91: 3463-3467.
172. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, Chang HY. 2010. Long noncoding RNAas modular scaffold of histone modification complexes. Science 329: 689-693.
173. Tycowski KT, Shu MD, Borah S, Shi M, Steitz JA. 2012. Conservation of a triple-helix-forming RNA stability element in noncoding and genomic RNAs of diverse viruses. Cell Rep 2: 26-32.
174. Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM, Cullen BR. 2008. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454: 780-783.
175. Umbach JL, Yen HL, Poon LL, Cullen BR. 2010. Influenza Avirus expresses high levels of an unusual class of small viral leader RNAs in infected cells. mBio 1: e00204-e00210.
176. Vereide DT, Seto E, Chiu YF, Hayes M, Tagawa T, Grundhoff A, Hammerschmidt W, Sugden B. 2014. Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene 33: 1258-1264.
177. Wassarman DA, Lee SI, Steitz JA. 1989. Nucleotide sequence of HSUR 5 RNA from Herpesvirus saimiri. Nucleic Acids Res 17: 1258.
178. Weinmann R, Brendler TG, Raskas HJ, Roeder RG. 1976. Low molecular weight viral RNAs transcribed by RNApolymerase III during adenovirus 2 infection. Cell 7: 557-566.
179. Whisnant AW, Kehl T, Bao Q, Materniak M, Kuzmak J, Lochelt M, Cullen BR. 2014. Identification of novel, highlyretroviral microRNAs in cells infected by bovine foamy virus. J Virol 88: 4679-4686.
180. White EA, Spector DH. 2007. Early viral gene expression and function. In Human herpesviruses: biology, therapy, and immunoprophylaxis (ed. Arvin A, et al.), pp. 264-294. Cambridge University Press, Cambridge, UK.
181. Wilson JL, Vachon VK, Sunita S, Schwartz SL, Conn GL. 2014. Dissection of the adenoviral VA RNAI central domain structure reveals minimum requirements for RNA-mediated inhibition of PKR. J Biol Chem 289: 23233-23245.
182. Wilusz JE, JnBaptiste CK, Lu LY, Kuhn CD, Joshua-Tor L, Sharp PA. 2012. A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails. Genes Dev 26: 2392-2407.
183. Wolin SL, Cedervall T. 2002. The La protein. Annu Rev Biochem 71: 375-403.
184. Wu TT, Su YH, Block TM, Taylor JM. 1996. Evidence that two latency-associated transcripts of herpes simplex virus type 1 are nonlinear. J Virol 70: 5962-5967.
185. Xie M, Steitz JA. 2014. Versatile microRNA biogenesis in animals and their viruses. RNA Biol 11: 673-681.
186. Xie M, Li M, Vilborg A, Lee N, Shu MD, Yartseva V, Sestan N, Steitz JA. 2013. Mammalian 5'-capped microRNA precursors that generate a single microRNA. Cell 155: 1568-1580.
187. Yajima M, Kanda T, Takada K. 2005. Critical role of Epstein-Barr virus (EBV)-encoded RNA in efficient EBV-induced B-lympho- cyte growth transformation. J Virol 79: 4298-4307.
188. Yang L, Aozasa K, Oshimi K, Takada K. 2004. Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction. Cancer Res 64: 5332-5337.
189. Yao Y, Smith LP, Nair V, Watson M. 2014. An avian retrovirus uses canonical expression and processing mechanisms to generate viral microRNA. J Virol 88: 2-9.
190. Yu X, Harris SL, Levine AJ. 2006. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 66: 4795-4801.
191. Zabolotny JM, Krummenacher C, Fraser NW. 1997. The herpes simplex virus type 1 2.0-kilobase latency-associated transcript is a stable intron which branches at a guanosine. J Virol 71: 4199-4208.
192. Zhang S, Sroller V, Zanwar P, Chen CJ, Halvorson SJ, Ajami NJ, Hecksel CW, Swain JL, Wong C, Sullivan CS, et al. 2014. Viral microRNA effects on pathogenesis of polyomavirus SV40 infections in syrian golden hamsters. PLoS Pathog 10: e1003912.
193. Zhao Y, Xu H, Yao Y, Smith LP, Kgosana L, Green J, Petherbridge L, Baigent SJ, Nair V. 2011. Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS Pathog 7: e1001305.
194. Zhong W, Ganem D. 1997. Characterization of ribonucleoprotein complexes containing an abundant polyadenylated nuclear RNA encoded by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J Virol 71: 1207-1212.
195. Ziegelbauer JM, Sullivan CS, Ganem D. 2009. Tandem array- based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat Genet 41: 130-134